Circio logoCircio logo

  • About
      • About Circio
      • Pipeline
      • Management Team
      • Board of Directors
      • Careers
  • circRNA
      • Circio AB
      • circVec platform
  • Clinical programs
      • ONCOS-102
      • KRAS program
      • Publications
  • Partnering
  • Investors
      • Press releases
      • Events
      • Financial Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
        • General Meetings
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Articles of Association
      • Contact
  • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
  • Contacts
    • About
      • About Circio
      • Our pipeline
      • Management Team
      • Board of Directors
      • Collaborations
      • Careers
    • circRNA
      • Circio AB
      • circVec platform
    • Clinical programs
      • ONCOS-102
      • KRAS program
      • Publications
    • Partnering
      • Partnering
    • Investors
      • Press releases
      • Events
      • Financial Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
      • General Meetings
      • Board of Directors
      • Nomination Committee
      • Committees
      • Management
      • Articles of Association
      • Contact
      • Subscribe
      • Contact
    • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
    • Contacts
      • Offices
      • Investors & Media
    All press releases
    • Press releases - Regulatory
    • Press releases - Non-regulatory
    2012
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2011
    • All years
    All subjects
    • Corporate news
    • Other
    November 14, 2012
    Press release - Non-regulatory

    Oncos Therapeutics appoints experienced industry leader Frans Wuite as President and CEO

    November 1, 2012
    Press release - Non-regulatory

    TG01 getting ready for phase I/II

    July 5, 2012
    Press release - Non-regulatory

    Oncos Therapeutics Announces Clinical Advisory Board

    May 29, 2012
    Press release - Non-regulatory

    Oncos Therapeutics successfully initiates Phase I clinical study

    March 14, 2012
    Press release - Non-regulatory

    Patient recruitment started in C1 study in Finland (in Finnish)

    January 25, 2012
    Press release - Non-regulatory

    Secures 13 MNOK for development of pancreas cancer vaccine TG01

    IR contact
    Dr Lubor Gaal
    Dr Lubor Gaal
    Chief Financial Officer
    lubor.gaal@circio.com
    (+34) 683 343 811
    Renate Birkeli
    Renate Birkeli
    Investor Relations
    renate.birkeli@circio.com
    (+47) 922 61 624
    Circio logo

    Circio Holding ASA is a biotechnology company developing novel circular RNA and immunotherapy medicines.

    • About
    • circRNA
    • Clinical programs
    • Partnering
    • Investors
    • Media
    • Contacts

    CONTACT

    Circio Holding ASA
    Email: contact@circio.com

    • Cookies
    • Privacy policy
    • STAY CONNECTED